CN1589133A - 不透射线的缓释药物系统 - Google Patents

不透射线的缓释药物系统 Download PDF

Info

Publication number
CN1589133A
CN1589133A CNA028228111A CN02822811A CN1589133A CN 1589133 A CN1589133 A CN 1589133A CN A028228111 A CNA028228111 A CN A028228111A CN 02822811 A CN02822811 A CN 02822811A CN 1589133 A CN1589133 A CN 1589133A
Authority
CN
China
Prior art keywords
biocompatible
thing
radio
activity component
delayed release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028228111A
Other languages
English (en)
Chinese (zh)
Inventor
M·布兰登
S·R·马蒂诺德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smart Drug Systems Inc
Original Assignee
Smart Drug Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smart Drug Systems Inc filed Critical Smart Drug Systems Inc
Publication of CN1589133A publication Critical patent/CN1589133A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA028228111A 2001-12-14 2002-12-09 不透射线的缓释药物系统 Pending CN1589133A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR9515 2001-12-14
AUPR9515A AUPR951501A0 (en) 2001-12-14 2001-12-14 Modified sustained release pharmaceutical system

Publications (1)

Publication Number Publication Date
CN1589133A true CN1589133A (zh) 2005-03-02

Family

ID=3833131

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028228111A Pending CN1589133A (zh) 2001-12-14 2002-12-09 不透射线的缓释药物系统

Country Status (9)

Country Link
US (1) US20050063907A1 (https=)
EP (1) EP1453482A4 (https=)
JP (1) JP2005517653A (https=)
CN (1) CN1589133A (https=)
AU (1) AUPR951501A0 (https=)
BR (1) BR0214159A (https=)
CA (1) CA2468986A1 (https=)
NZ (1) NZ532378A (https=)
WO (1) WO2003051335A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102355891A (zh) * 2009-03-17 2012-02-15 英特威国际有限公司 大环内酯药物递送系统

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
AU2003267309A1 (en) 2000-11-16 2004-04-08 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
CN1638747A (zh) * 2002-01-24 2005-07-13 斯玛特药物系统公司 持续释放药物组合物
US8920826B2 (en) * 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
NZ581461A (en) * 2003-11-13 2011-04-29 Psivida Inc Injectable sustained release delivery devices
TWI434676B (zh) * 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
DE102006021016A1 (de) * 2006-05-05 2007-11-15 Dürschinger, Günter Chemisch aktivierbare Kapsel für die Durchgangsprüfung und Behandlung des Darm-Trakts
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8475823B2 (en) * 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US20100203102A1 (en) * 2009-02-10 2010-08-12 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using bupivacaine and an anti-onflammatory agent
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
JPWO2016204026A1 (ja) * 2015-06-15 2018-06-14 ｓｅｖｅｎ ｄｒｅａｍｅｒｓ ｌａｂｏｒａｔｏｒｉｅｓ株式会社 鼻腔留置デバイス
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
ES2987079T3 (es) 2020-08-24 2024-11-13 Edwards Lifesciences Corp Sistemas para alinear una comisura de una válvula cardiaca protésica con una comisura de una válvula nativa

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD205069A1 (de) * 1982-04-14 1983-12-21 Univ Ernst Moritz Arndt Verfahren zur herstellung eines therapeutischen mittels
US4866132A (en) * 1986-04-17 1989-09-12 The Research Foundation Of State University Of New York Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom
DE3775880D1 (https=) * 1986-09-18 1992-02-20 London School Of Pharmacy Innovations Ltd., London, Gb
JPH03504382A (ja) * 1988-05-20 1991-09-26 ザ　リポソーム　カンパニー，インコーポレイテッド 高比率活性剤：脂質複合体
US5674468A (en) * 1992-03-06 1997-10-07 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
ATE184491T1 (de) * 1992-03-06 1999-10-15 Nycomed Imaging As Verbesserungen in bezug auf kontrastmittel
GB9204918D0 (en) * 1992-03-06 1992-04-22 Nycomed As Chemical compounds
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
DE19580865D2 (de) * 1994-08-17 1998-03-19 Boston Scient Corp Implantat, Implantationsverfahren und Applikationsvorrichtung
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
UA54505C2 (uk) * 1997-04-03 2003-03-17 Гілфорд Фармасьютікалз Інк. Полімери, що біологічно розкладаються, зшиті фосфатами, композиції, вироби і способи для їх виготовлення і використання
EP0938894A1 (en) * 1998-02-16 1999-09-01 Biomat B.V. Implantable radiopaque device and use thereof
IL133196A0 (en) * 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
US6599448B1 (en) * 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102355891A (zh) * 2009-03-17 2012-02-15 英特威国际有限公司 大环内酯药物递送系统

Also Published As

Publication number Publication date
JP2005517653A (ja) 2005-06-16
NZ532378A (en) 2005-02-25
CA2468986A1 (en) 2003-06-26
US20050063907A1 (en) 2005-03-24
AUPR951501A0 (en) 2002-01-24
EP1453482A4 (en) 2006-09-20
WO2003051335A1 (en) 2003-06-26
BR0214159A (pt) 2004-09-28
EP1453482A1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
CN1541090A (zh) 持久释放药物组合物的制备
CN1731988A (zh) 缓释药物组合物
JP4913321B2 (ja) 徐放性医薬組成物
JP2013049705A (ja) 持続放出医薬組成物
CN1589133A (zh) 不透射线的缓释药物系统
AU2002344685A1 (en) Sustained release pharmaceutical composition
AU2002344686A1 (en) Sustained release delivery system
CN1198599C (zh) 长期释放药物的缓释性制剂
CN1638747A (zh) 持续释放药物组合物
CN1522158A (zh) 寄生虫疾病的治疗方法
AU2002315568B2 (en) Preparation of sustained release pharmaceutical composition
AU2002366248A1 (en) Radioopaque sustained release pharmaceutical system
AU2002315568A1 (en) Preparation of sustained release pharmaceutical composition
JP2001199879A (ja) 薬物放出製剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication